Lung Squamous Cell Carcinoma — Trials

Lung Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

141 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 46%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04266730	Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab(PANDA-VAC)	suspended	Phase 1	6	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Apr 23, 2026	clinicaltrials
NCT00909558	Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer	suspended	Phase 1	24	Envita Medical Center, Inc.INDUSTRY	1	Feb 24, 2010